First Manhattan Portfolio holdings
AUM
$35.4B
1-Year Return
24.51%
This Quarter Return
+11.24%
1 Year Return
+24.51%
3 Year Return
+86.41%
5 Year Return
+172.47%
10 Year Return
+337.52%
AUM
$27.3B
AUM Growth
+$3.67B
(+16%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
61.8%
Holding
1,843
New
200
Increased
397
Reduced
428
Closed
157
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$1.7B |
| 2 |
Brookfield Asset Management
BAM
|
$111M |
| 3 |
ASML
ASML
|
$90.4M |
| 4 |
Lowe's Companies
LOW
|
$81.8M |
| 5 |
Oracle
ORCL
|
$27.2M |
Top Sells
| 1 |
Brookfield
BN
|
$109M |
| 2 |
Apple
AAPL
|
$106M |
| 3 |
Meta Platforms (Facebook)
META
|
$72.4M |
| 4 |
Domino's
DPZ
|
$55.5M |
| 5 |
Amazon
AMZN
|
$52.9M |
Sector Composition
| 1 | Financials | 49.2% |
| 2 | Technology | 13.2% |
| 3 | Healthcare | 10.72% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Communication Services | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enbridge
ENB
$105B
| $57.8M | 0.21% |
1,477,459
-19,303
| -1% | -$755K |
|
52
Pfizer
PFE
$139B
| $57.1M | 0.21% |
1,113,438
-11,152
| -1% | -$571K |
|
53
Canadian Natural Resources
CNQ
$64.9B
| $53.4M | 0.2% |
1,923,718
-18,914
| -1% | -$525K |
|
54
Charles Schwab
SCHW
$176B
| $51.7M | 0.19% |
621,435
+177,118
| +40% | +$14.7M |
|
55
United Therapeutics
UTHR
$17.3B
| $51M | 0.19% |
183,400
| – | – |
|
56
Capital One
COF
$143B
| $50.9M | 0.19% |
547,685
+14,784
| +3% | +$1.37M |
|
57
Vanguard S&P 500 ETF
VOO
$726B
| $48.1M | 0.18% |
136,983
-15,320
| -10% | -$5.38M |
|
58
Stryker
SYK
$150B
| $47.1M | 0.17% |
192,692
+16,276
| +9% | +$3.98M |
|
59
Cencora
COR
$57.7B
| $43.1M | 0.16% |
259,887
-20,859
| -7% | -$3.46M |
|
60
Arrowhead Research
ARWR
$3.86B
| $41.6M | 0.15% |
1,025,654
-79,933
| -7% | -$3.24M |
|
61
Walt Disney
DIS
$213B
| $41.1M | 0.15% |
472,862
-69,789
| -13% | -$6.06M |
|
62
Procter & Gamble
PG
$373B
| $41M | 0.15% |
275,209
-5,557
| -2% | -$828K |
|
63
IQVIA
IQV
$30.8B
| $40M | 0.15% |
195,145
-6,676
| -3% | -$1.37M |
|
64
Moody's
MCO
$89.5B
| $40M | 0.15% |
143,394
-1,844
| -1% | -$514K |
|
65
Hologic
HOLX
$14.5B
| $38.7M | 0.14% |
516,766
+66
| +0% | +$4.94K |
|
66
JPMorgan Chase
JPM
$831B
| $36.9M | 0.14% |
276,937
-3,667
| -1% | -$489K |
|
67
Ingredion
INGR
$8.23B
| $36.3M | 0.13% |
370,470
-4,186
| -1% | -$410K |
|
68
Amgen
AMGN
$152B
| $36M | 0.13% |
139,782
-4,478
| -3% | -$1.15M |
|
69
Match Group
MTCH
$8.98B
| $35.7M | 0.13% |
859,983
-296,156
| -26% | -$12.3M |
|
70
Immunocore
IMCR
$1.77B
| $35M | 0.13% |
613,749
-182,100
| -23% | -$10.4M |
|
71
AB InBev
BUD
$115B
| $35M | 0.13% |
583,147
-52,465
| -8% | -$3.15M |
|
72
Graco
GGG
$14.1B
| $34.6M | 0.13% |
549,773
+144,045
| +36% | +$9.07M |
|
73
Starbucks
SBUX
$98.9B
| $33.7M | 0.12% |
374,212
-38,199
| -9% | -$3.44M |
|
74
Eli Lilly
LLY
$663B
| $32.2M | 0.12% |
88,070
-33,078
| -27% | -$12.1M |
|
75
Evolus
EOLS
$476M
| $30.2M | 0.11% |
4,016,138
-18,800
| -0.5% | -$141K |
|